Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions — proceedings from the CEC Summit 2018-Reference-Cited by-同舟云学术

Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions — proceedings from the CEC Summit 2018

Published:2022-04 Issue: Volume:246 Page:93-104
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Sharma Abhinav,Mahaffey Kenneth W.,Gibson Charles Michael,Hicks Karen A.,Alexander Karen P.,Ali Maria,Chaitman Bernard R.,Held Claes,Hlatky Mark,Jones WIlliam Schuyler,Mehran Roxana,Menon Venu,Rockhold Frank W.,Seltzer Jonathan,Spitzer Ernest,Wilson Matthew,Lopes Renato D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Do we need to adjudicate major clinical events?;Granger;Clinical Trials,2008

2. Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition;Zannad;Eur Heart J,2008

3. 2017 cardiovascular and stroke endpoint definitions for clinical trials;Hicks;Circulation,2018

4. Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document;Garcia-Garcia;Circulation,2018

5. Frequency, regional variation, and predictors of undetermined cause of death in cardiometabolic clinical trials: a pooled analysis of 9259 deaths in 9 trials;Fanaroff;Circulation,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data Interoperability for Ambulatory Monitoring of Cardiovascular Disease: A Scientific Statement From the American Heart Association;Circulation: Genomic and Precision Medicine;2024-06

2. A hybrid automated event adjudication system for clinical trials;Clinical Trials;2023-02-03

3. No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines;Enfermedades Infecciosas y Microbiología Clínica;2023-01

4. No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines;Enfermedades infecciosas y microbiologia clinica (English ed.);2023-01